Gilles Breuzard

7PUBLICATIONS
11CO-AUTHORS
Characterisation of biological macromoleculesGene and molecular therapyMolecular targetsMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 27, 2026
Special Issue "New Drugs Regulating Cytoskeletons in Human Health and Diseases".

Gilles Breuzard, Maxime Robin, Hervé Kovacic

|Nov 09, 2024
Therapeutic Contribution of Tau-Binding Thiazoloflavonoid Hybrid Derivatives Against Glioblastoma Using Pharmacological Approach in 3D Spheroids.

Emmanuelle T Relave, Rayane Hedna, Attilio Di Maio

|Oct 28, 2023
2-Aminothiazole-Flavonoid Hybrid Derivatives Binding to Tau Protein and Responsible for Antitumor Activity in Glioblastoma.

Rayane Hedna, Attilio DiMaio, Maxime Robin

|Dec 11, 2022
Myotoxin-3 from the Pacific Rattlesnake Crotalus oreganus oreganus Venom Is a New Microtubule-Targeting Agent.

María Cecilia González García, Caroline Radix, Claude Villard

|Nov 11, 2022
Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma.

Rayane Hedna, Hervé Kovacic, Alessandra Pagano

|Nov 27, 2021
Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis.

Alessandra Pagano, Gilles Breuzard, Fabrice Parat

Pageof 2